Bavarian Officials Back Fixed Fees, Oppose PTA Substitutions Amid Pharmacy Protests

As pharmacies across Germany prepare for nationwide demonstrations, the debate over fair remuneration and regulatory reforms in the pharmaceutical sector intensifies. The upcoming protests, scheduled to take place at four major locations--Berlin, Düsseldorf, Hannover, and Munich--highlight growing calls for an adjusted compensation system for pharmacies. These actions occur while the Pharmacy Care Advancement Act (ApoVWG) is under legislative review, prompting stakeholders to express their perspectives on the proposed changes.

Central to the discussion is the proposed increase in the fixed fee paid to pharmacies for dispensing prescription medications. Health officials from several German states, including Bavaria, have voiced support for this adjustment, emphasizing the need to strengthen local pharmacies and ensure comprehensive pharmaceutical care. They argue that an adequate remuneration framework is vital for pharmacies to meet their obligations and adapt to new public health responsibilities, such as expanded preventive services.

Judith Gerlach, Bavaria's Health Minister, has publicly endorsed the plan to raise the fixed fee, stating that local pharmacies require prompt federal support to maintain their coverage across communities. According to her, improved compensation is essential not only for sustaining the delivery of prescription drugs but also for enabling pharmacies to expand their range of services. The potential for increased responsibilities, such as broader prevention initiatives, would require additional skilled staff, which in turn demands appropriate financial resources.

Despite support for higher fees, skepticism remains regarding proposed changes to substitute regulations involving pharmacy technicians (PTA). The federal health ministry has suggested modifications that would allow PTAs to temporarily substitute for pharmacists under specific conditions. However, this measure has faced resistance from various state governments, including Bavaria. Regional authorities, referencing a collective statement from the federal states, contend that such substitution rules may undermine quality and safety standards in pharmaceutical care. The federal government's response has been to maintain its intention to proceed with a revised, more restrictive version of the PTA substitution policy.

Beyond the issues of remuneration and personnel, the protests also draw attention to broader structural concerns, such as the operation of branch pharmacies and the overall regulatory environment. Representatives from Berlin, North Rhine-Westphalia, and Lower Saxony have all acknowledged the legitimacy of the pharmacies' demands, with some officials noting that further adjustments to the legislative proposals may still be required.

On the day of the protests, most pharmacies nationwide are expected to close temporarily, with emergency services remaining operational to ensure continued access to essential medications. Organizers have arranged central rallies in key cities, aiming to demonstrate the sector's unity and underline the urgency of their concerns to lawmakers.

The ongoing dialogue between pharmacy representatives, state health officials, and the federal government illustrates the complexity of reforming Germany's pharmaceutical sector. As the legislative process for the ApoVWG progresses, the outcomes of these discussions--and the impact of the coordinated protests--will likely shape the future role and sustainability of community pharmacies across the country.